BDXBecton Dickinson

SPX

Data as of Oct 15, 2026 · 09:38 p.m.

$193.85

+2.63%

Unlock full analysis
52/100
● Neutral Zone

No directional signal

The canonical InvestCompass profile currently shows mixed evidence without a clear directional edge.

Global score threshold

Buy Zone ≥ 80
Partial Buy Zone ≥ 65
Neutral Zone ≥ 45
Partial Sell Zone ≥ 25
Sell Zone < 25

Becton Dickinson

BDX
Market
SPX
Sector:
Healthcare
Industry
Medical Instruments & Supplies

About the company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care

Global score detail

Breakdown of the 4 modules in the global score (Macro, Sector, Fundamental, Technical)

1. Macro(15%)57/100
Sector(30%)53/100
Fundamental(25%)48/100
Technical(30%)52/100
Macro — Full analysis workspace
Fundamental — Full analysis workspace
Sector — Full analysis workspace
Technical — Full analysis workspace
Fundamentals and peer comparison
Signals and trade plan

Current Price

$193.85

Period High

$191.94

Period Low

$124.47

Analyst Target

$194.08

0.1% upside

Price history

Loading chart...

Moving averages
Technical indicators
Technical indicators
Technical indicators
Technical indicators
Moving averages
Technical indicators
AI and news commentary
AI and news commentary

InvestCompass provides analysis tools, not financial advice. Data may be delayed.